Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Mosquitoes Sense Bed Net Insecticides through Their Legs

Researchers at the Liverpool School of Tropical Medicine have identified a previously unknown mechanism by which mosquitoes that carry the malaria parasite can become resistant to the insecticide that is used to impregnate bed nets. The scientists found that p

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Researchers at the Liverpool School of Tropical Medicine have identified a previously unknown mechanism by which mosquitoes that carry the malaria parasite can become resistant to the insecticide that is used to impregnate bed nets. The scientists found that pyrethroid-resistant Anopheles gambiae and Anopheles coluzzii mosquitoes expressed high levels of a chemical binding protein known as sensory appendage protein (SAP2), in their legs, which comes into contact with the insecticide when the insects land on the nets. Their studies linked high expression of SAP2 with resistance to pyrethroid insecticides in long-lasting insecticidal nets (LLINs) that have been so successful in reducing the incidence of malaria in many areas of Africa. Experiments showed that partial deletion of SAP2 rendered previously pyrethroid-resistant Anopheles mosquitoes susceptible to the insecticide, whereas overexpressing SAP2 rendered otherwise susceptible mosquitoes resistant to pyrethroids.

“We have found a completely new insecticide resistance mechanism that we think is contributing to the lower than expected efficacy of bed nets,” said Victoria Ingham, PhD, postdoctoral research associate and first author on the team’s published paper in Nature. “The protein, which is based in the legs, comes into direct contact with the insecticide as the insect lands on the net, making it an excellent potential target for future additives to nets to overcome this potent resistance mechanism.” Ingham and colleagues reported their findings in a paper titled, “A sensory appendage protein protects malaria vectors from pyrethroids.”

The widespread use of pyrethroid-impregnated bed nets has been instrumental in reducing malaria-associated disease and death rates in Africa since the beginning of the century, the authors said. “However, worryingly, after many years of progress, gains in malaria control are now stalling, with an estimated 219 million cases and 435,000 malaria-associated deaths across Africa in 2017 prompting a re-examination of the effectiveness of the primary prevention tools.” The widespread use of LLINs has forced selection pressures on the mosquitoes to develop mechanisms that confer resistance to pyrethroids. As a result, insecticide-treated bed nets containing the synergist piperonyl butoxide (PBO) in addition to pyrethroid insecticides have now been introduced. The synergist targets one of the most widespread and most potent known resistance mechanisms caused by cytochrome P450s, and so re-establishes insect susceptibility to pyrethroids.

“By blocking this resistance mechanism, PBO–pyrethroid nets restore insecticide susceptibility, leading to a reduction in malaria cases in areas in which metabolic resistance prevails,” the authors stated. However, not all pyrethroid-resistant mosquito populations can be targeted by the use of PBO to restore pyrethroid susceptibility, and Anopheles mosquitoes are developing new resistance mechanisms. By screening gene expression data from mosquito populations in Burkina Faso and the Côte d’Ivoire, which are areas with “particularly high pyrethroid resistance and low PBO synergism,” the investigators found that a family of chemosensory proteins (CSPs), known as sensory appendage proteins, was overexpressed in resistant mosquito populations. CSPs are small, soluble proteins that are only found in arthropods, and they transport small hydrophobic molecules as part of a chemical communication system.

The team’s experiments first showed that insecticide exposure induced expression of the sensory appendage protein, SAP2. They then demonstrated that susceptibility to three different pyrethroid insecticides tested could be restored in highly pyrethroid-resistant mosquitoes, by using RNA interference (RNAi) to almost completely silence the SAP2 gene. Conversely, the team noted, “ … overexpression of SAP2 in an insecticide-susceptible population significantly increased pyrethroid resistance, directly linking the function of this protein to insecticide resistance.” Tests confirmed that SAP2 bound directly to all three pyrethroid insecticides tested.

The team then analyzed the genomes of West African Anopheles populations over time using a combination of data from the Anopheles gambiae 1000 Genomes project and from direct sequencing. The results indicated that a “selective sweep” had occurred at the locus where CSP genes are found, over the time period during which resistance to pyrethroid insecticides also increased. A selective sweep refers to when a beneficial mutation becomes fixed in a population and increases in frequency as a result of natural selection, and also reduces variation in linked sites.

“Our results show that SAP2, a chemosensory protein with no previous known function in insecticide resistance, has a key role in conferring pyrethroid resistance in the A. gambiae species complex through the binding of insecticides at the first point of mosquito contact with bed nets,” the authors commented. “Given its strong binding to pyrethroid insecticides, it is possible that SAP2 acts by sequestering the insecticide directly, thus either preventing the function of the insecticide on the nervous system or facilitating its detoxification. Notably, longitudinal sequencing of field samples and available transcriptomic data from wild collections show that this mechanism is being selected for in multiple countries in West Africa, highlighting its relevance in field settings.”

The researchers claim that discovery of the new resistance mechanism may help in the development of new synergists that could be used to restore pyrethroid susceptibility in some populations of resistant mosquitoes. “… the identification of this previously undescribed insecticide sequestration mechanism offers the concrete possibility to restore the effectiveness of pyrethroid insecticides in natural mosquito populations through the identification of new targets for inhibitors that can be incorporated into bed nets, in an analogous manner to the incorporation of PBO into nets—this may prove to be critical for the elimination of malaria across Africa,” the team concluded.

“Long-lasting insecticide-treated bed nets remain one of the key interventions in malaria control,” stated Hilary Ranson, PhD, senior author on the paper. “It is vital that we understand and mitigate for resistance within mosquito populations in order to ensure that the dramatic reductions in disease rates in previous decades are not reversed. This newly discovered resistance mechanism could provide us with an important target for both the monitoring of insecticide resistance and the development of novel compounds able to block pyrethroid resistance and prevent the spread of malaria.”

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Undruggable or unscreenable?

Another obstacle to discovering new PPI inhibitors is the lack of libraries designed to hunt for them, points out Philippe Roche, PhD, senior scientist at the Integrative Structural and Chemical Biology team at the Cancer Research Center of Marseilles, France. “If you screen PPIs using libraries that were designed for kinases or GPCRs, that’s why you don’t get a lot of good results,” he says. To that end, his group began assembling a library focused on orthosteric inhibitors of PPIs. The result was 2P2Idb, a hand-curated, structural database cataloguing orthosteric inhibitors of PPIs for which the interface had been 3D characterized. From analyzing these known PPI inhibitors, and what structures they had in common, Roche and his colleagues developed a model to predict whether compounds would likely inhibit PPIs. Using this method, 2P2Idb creates an enriched screening library that dramatically increases the hit rate compared to standard libraries. Having proven their success with a small library of 1600 compounds, they are in the process of expanding the library to 10,000 compounds. Once that’s published, “the idea is to make this library available to labs around the world,” Roche says. “We will provide the library free of charge for people to be able to screen PPI targets.”

Source: www.genengnews.com ↗
02How stable is the antibody?

A crucial question often addressed during preclinical development focuses on the in vivo stability of therapeutic antibodies. Increasing the half-life of a therapeutic antibody has several benefits ranging from higher treatment efficacy to increased advantages for the patients who will have a fewer number of therapy sessions and a reduced cost. Given these compelling benefits, following the identification of therapeutic antibodies with the desired specificity, developers usually subject them to a refinement step to increase their stability. This process is often hindered by the lack of reliable experimental tools to predict the half-life of antibodies in patients. The major hurdle of using mouse models to predict antibody stability in the serum lies in the way immunoglobulin proteins are processed by the organism. In mammals, most proteins circulating in the serum undergo constant uptake by endothelial cells and are routed through the endosomes to the lysosomal compartment for degradation. In the endosomes, immunoglobulin G (IgG) proteins are recognized and bound by a transmembrane protein, called the neonatal Fc receptor (FcRn), which mediates their recycling to the plasma membrane and subsequent release back into the serum. As a result, the half-life of IgGs are significantly extended by this mechanism. Since most therapeutic antibodies belong to the IgG class, this recycling system is very relevant for their relative stability in the body. Remarkably, the relative affinity between IgGs and FcRn is extremely disparate between different species, with the mouse receptor showing a much higher affinity than its human counterpart.

Source: www.genengnews.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →